US 11357817
Immunoproteasome inhibitor
granted A61KA61K38/06A61P
Quick answer
US patent 11357817 (Immunoproteasome inhibitor) held by The Regents of the University of California expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/06, A61P, A61P33/06